How many stocks are there of BioCorRx?
The current number of stocks of BioCorRx is 8.34 M undefined.
BioCorRx Stocks 2024
BioCorRx Stocks
8.34 M
Ticker
BICX
ISIN
US09073C2052
WKN
A1XERB
In 2024, BioCorRx had 8.34 M outstanding stocks, a 0% change from the 8.34 M stocks in the previous year.
The BioCorRx Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2025e | 8.34 |
| 2024e | 8.34 |
| 2023 | 8.34 |
| 2022 | 7.2 |
| 2021 | 6.49 |
| 2020 | 5.38 |
| 2019 | 3.52 |
| 2018 | 2.51 |
| 2017 | 2.33 |
| 2016 | 1.7 |
| 2015 | 1.55 |
| 2014 | 1.39 |
| 2013 | 1.17 |
| 2012 | 1.06 |
| 2011 | 0.51 |
| 2010 | 0.37 |
| 2009 | 4.29 |
| 2008 | 0.02 |
BioCorRx shares outstanding US09073C2052 · A1XERB
The number of shares was BioCorRx in 2023 — This indicates how many shares 8.344 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue BioCorRx earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates BioCorRx's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of BioCorRx’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BioCorRx's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2008 | 20,000 Aktien |
| 2009 | 4.29 M Aktien |
| 2010 | 370,000 Aktien |
| 2011 | 510,000 Aktien |
| 2012 | 1.06 M Aktien |
| 2013 | 1.17 M Aktien |
| 2014 | 1.39 M Aktien |
| 2015 | 1.55 M Aktien |
| 2016 | 1.7 M Aktien |
| 2017 | 2.33 M Aktien |
| 2018 | 2.51 M Aktien |
| 2019 | 3.52 M Aktien |
| 2020 | 5.38 M Aktien |
| 2021 | 6.49 M Aktien |
| 2022 | 7.2 M Aktien |
| 2023 | 8.34 M Aktien |
| 2024e | 8.34 M Aktien |
| 2025e | 8.34 M Aktien |
BioCorRx Aktienanalyse
What does BioCorRx do?
The company BioCorRx Inc is a US-American company that was founded in 2008 and is headquartered in Anaheim, California. BioCorRx specializes in the development and marketing of innovative treatment methods for alcohol and drug dependency. The history of BioCorRx began with the introduction of its flagship product, the BioCorRx Recovery Program, which is based on a novel medical technology called Naltrexone/Buprenorphine Implant. Unlike traditional methods of treating alcohol and drug addiction, which typically rely on medication and psychotherapeutic support, the BioCorRx Recovery Program is an implantable, long-term treatment system that continuously delivers the active ingredient Naltrexone or Buprenorphine into the patient's body. The idea behind this is that the active ingredients prevent withdrawal symptoms and thereby reduce the risk of relapse. In recent years, BioCorRx has expanded its product portfolio and expanded its business activities to new segments in order to further drive the company's growth. This includes, for example, the field of telemedicine services, which allow BioCorRx to offer its treatment technology and medical services through online communication. Telemedicine services such as virtual patient consultation or online group therapy programs are particularly in demand in times of COVID-19. Another focus of BioCorRx is the management of medical personnel. Studies have shown that good patient care and counseling heavily influence the success of treatment. BioCorRx has now also developed its own platform that eases and improves the management, training, and monitoring of medical staff. BioCorRx also utilizes the concept of franchise systems to market its products and services. The franchise system offers medical professionals and organizations working in the field of addiction treatment the opportunity to open their own BioCorRx clinic and offer the company's products and services in their local market. Each clinic is advised and supported by BioCorRx and must adhere to certain standards and quality criteria. In the future, BioCorRx plans to further diversify its product offering and develop new technologies to improve treatment options for alcohol and drug dependents. An example of such a technology is medication based on Ibogaine. BioCorRx has already started initial research in this direction and is actively working on pre-clinical studies. Overall, BioCorRx is a company that primarily focuses on innovative technologies for the treatment of addiction. The company has experienced substantial growth in recent years by expanding its product range and customer base, and focusing on the areas of telemedicine, personnel management, and franchise systems. With its forward-thinking technologies and strong emphasis on quality and patient satisfaction, BioCorRx is expected to continue playing an important role in addiction treatment in the years to come. BioCorRx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating BioCorRx's Shares Outstanding
BioCorRx's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in BioCorRx’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding BioCorRx’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in BioCorRx’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about BioCorRx stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of BioCorRx are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of BioCorRx evolved in recent years?
The number of shares of BioCorRx has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. BioCorRx as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of BioCorRx?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does BioCorRx pay?
Over the past 12 months, BioCorRx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCorRx is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCorRx?
The current dividend yield of BioCorRx is .
When does BioCorRx pay dividends?
BioCorRx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCorRx?
BioCorRx paid dividends every year for the past 0 years.
What is the dividend of BioCorRx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCorRx located?
BioCorRx is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCorRx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCorRx from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did BioCorRx pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of BioCorRx in the year 2023?
In the year 2023, BioCorRx distributed 0 USD as dividends.
In which currency does BioCorRx pay out the dividend?
The dividends of BioCorRx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCorRx
Our stock analysis for BioCorRx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCorRx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
